NeueHealth Future Growth
Future criteria checks 0/6
NeueHealth's revenue is forecast to decline at 1.4% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Healthcare earnings growth | 15.9% |
Revenue growth rate | -1.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 13 Mar 2024 |
Recent future growth updates
Recent updates
Bright Health Group: Stock Price Has Been Too Heavily Beaten Down
Jan 19Bright Health Group expects FY23 revenue to be below consensus
Jan 10Bright Health receives non-compliance notice from NYSE
Dec 12Bright Health Group reports Q3 mixed earnings; revises Fy22 guidance
Nov 09Bright Health narrows footprint to only offer Medicare Advantage in California, Florida
Oct 11Analysts Have Been Trimming Their Bright Health Group, Inc. (NYSE:BHG) Price Target After Its Latest Report
Aug 13Bright Health Group Takes Cost Actions To Effect Turnaround
Jul 21Bright Health Group: Examining A Dumpster Fire
Jan 04Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 1,129 | N/A | N/A | N/A | 1 |
12/31/2024 | 1,008 | N/A | N/A | N/A | 1 |
12/31/2023 | 1,161 | -563 | -2,729 | -2,727 | N/A |
9/30/2023 | 2,756 | -1,078 | -2,281 | -2,273 | N/A |
6/30/2023 | 2,680 | -660 | -1,231 | -1,216 | N/A |
3/31/2023 | 2,532 | -700 | -889 | -865 | N/A |
12/31/2022 | 751 | -521 | 207 | 234 | N/A |
9/30/2022 | -1,031 | -373 | -71 | -39 | N/A |
6/30/2022 | -145 | -513 | 277 | 312 | N/A |
3/31/2022 | 819 | -450 | 192 | 223 | N/A |
12/31/2021 | 1,513 | -330 | 52 | 82 | N/A |
9/30/2021 | 3,427 | -534 | 139 | 165 | N/A |
6/30/2021 | 2,700 | -293 | 336 | 353 | N/A |
3/31/2021 | 1,883 | -266 | 193 | 204 | N/A |
12/31/2020 | 515 | -161 | -64 | -57 | N/A |
12/31/2019 | 281 | -125 | -9 | -8 | N/A |
12/31/2018 | 131 | -63 | -28 | -27 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if NEUE's forecast earnings growth is above the savings rate (2.4%).
Earnings vs Market: Insufficient data to determine if NEUE's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if NEUE's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: NEUE's revenue is expected to decline over the next 3 years (-1.4% per year).
High Growth Revenue: NEUE's revenue is forecast to decline over the next 3 years (-1.4% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NEUE's Return on Equity is forecast to be high in 3 years time